MSPAS No. 2026-HES-CD238 ACQUISITION OF KETOROLAC FOR ESCUINTLA HOSPITAL.

This tender, identified as MSPAS No. 2026-HES-CD238, concerns the acquisition of Ketorolac for the Hospital de Escuintla. The specific item required is Ketorolaco trometamina. The procurement method employed was Direct Purchase with Electronic Offer, as per Article 43, Inciso b) of the Public Procurement Law (LCE). The contracting entity responsible for this process was the Ministry of Public Health (Ministerio de Salud Pública). The tender has been awarded. This procurement is crucial for ensuring the availability of essential pain management medication at the Hospital de Escuintla, a key healthcare facility serving the region. The direct purchase method, coupled with electronic bidding, was likely chosen to expedite the process and potentially achieve competitive pricing for this specific pharmaceutical product. The successful award indicates that a supplier has been selected to provide the required Ketorolac, fulfilling the Ministry of Public Health's objective to equip the hospital with necessary medical supplies. Further details regarding the awarded contract value, the specific supplier, and the delivery timeline would typically be available in the official award notice.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals. Located in Guatemala, Latin America, this opportunity is open to firms and consortiums.

Published through Guatecompras, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.